H-D-Ile-OBzl · p-tosylate

H-D-Ile-OBzl · p-tosylate is a protected, stereochemically specified amino acid derivative based on D-iodo? (H-D-Ile) featuring an isoleucine backbone with a benzyl ester (OBzl) at the carboxyl terminus and a p-toluenesulfonate counterion. The molecule contains an α-amino group in the N-acylated/blocked form indicated by the "H-" prefix, while the side chain retains the branched aliphatic functionality characteristic of isoleucine and the p-tosylate provides ionic association for handling and salt formation. In peptide and amino acid synthesis workflows, this protected ester/salt form can serve as a substrate or intermediate for stepwise assembly and derivatization while the carboxyl is masked as a benzyl ester to control chemoselectivity during coupling and subsequent transformations.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP27494

CAS No:80174-45-4

Synonyms/Alias:D-ISOLEUCINE-OBZLP-TOSYLATE;80174-45-4

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C20H27NO5S
M.W/Mr.
393.5

H-D-Ile-OBzl · p-tosylate is a protected amino acid derivative in which D-configuration is retained at the α-carbon of isoleucine, while the carboxyl group is present as a benzyl ester (OBzl) and the amino functionality is masked as a p-tosylate (tosyl-protected amine). The molecule therefore presents a chiral, sterically differentiated side chain typical of Ile, together with a sulfonamide-protected nitrogen and an ester-protected carboxyl group that modulate nucleophilicity and control chemoselective transformations. The benzyl ester can be removed under hydrogenolysis-compatible conditions, enabling downstream conversion to free carboxylic acid for peptide coupling, whereas the tosyl group supports stability during acylation steps and can be removed to reveal an amine for further functionalization. This combination of stereochemical definition and orthogonal protection makes the compound a practical chiral intermediate for protected amino acid synthesis, peptide building block preparation, and controlled derivatization in synthetic and biochemical chemistry.

1. Protected Amino Acid Synthesis

H-D-Ile-OBzl · p-tosylate supports protected amino acid chemistry workflows by pairing a benzyl ester carboxyl protection with a tosyl-protected amine, enabling selective activation and coupling at the appropriate stage. The D-stereocenter and the Ile side-chain branching provide a defined chiral environment that can be carried into peptide sequences or used to build stereochemically controlled analogs. Benzyl ester stability under many coupling conditions helps prevent premature acid formation, while tosyl protection can withstand typical peptide bond-forming reagents until deprotection is desired. Downstream conversion to the corresponding free amine and free acid forms a controlled entry point for peptide building block preparation and chiral intermediate generation in fine chemical synthesis.

2. Peptide Coupling Chemistry

H-D-Ile-OBzl · p-tosylate is suitable for peptide synthesis strategies that require a protected D-Ile residue compatible with amide bond construction. The benzyl ester can be transformed into a carboxyl-activated species after deprotection or via staged functional group interconversions, while the tosyl-protected nitrogen prevents side reactions and helps maintain chemoselectivity during coupling. The steric profile of the Ile side chain influences coupling reactivity and conformational preferences in the growing peptide chain, supporting structure-defined peptide analog construction. Resulting D-Ile-containing peptides and peptidomimetic fragments can be accessed for research-grade sequence assembly, fragment ligation, and iterative protected amino acid incorporation.

3. Peptidomimetic And SAR Studies

H-D-Ile-OBzl · p-tosylate enables peptidomimetic construction and structure-activity relationship studies through incorporation of a stereodefined D-amino acid motif into bioactive scaffolds. The orthogonal protection pattern supports controlled functional group unveiling, allowing sequential introduction of additional substituents or further derivatization without disrupting the chiral center. The tosyl-protected amine and benzyl ester functionality provide handles for downstream transformations that can tune polarity, hydrogen-bonding capacity, and local backbone geometry in analog libraries. Generated D-Ile-containing fragments can serve as defined stereochemical units for SAR mapping, conformational probing, and medicinal chemistry intermediate preparation.

4. Chemical Biology Labeling

H-D-Ile-OBzl · p-tosylate can be applied in chemical biology workflows where protected amino acid derivatives are needed to install D-Ile-containing motifs into larger constructs under controlled deprotection sequences. The benzyl ester and tosyl group allow staged exposure of reactive termini, supporting coupling to activated carboxylates or amines in a manner that minimizes uncontrolled side reactions. The chiral Ile side chain can influence binding-site recognition and can be used to control stereochemical outcomes in labeling reagents or probe precursors. Downstream deprotection and functional group conversion can yield intermediates for conjugation to biomolecule scaffolds, enabling preparation of stereochemically defined probes and modified peptides used in biochemical research.

5. Pharmaceutical Intermediate Preparation

H-D-Ile-OBzl · p-tosylate aligns with pharmaceutical intermediate preparation by providing a protected, stereodefined amino acid building block for controlled manufacturing routes. The benzyl ester and tosyl-protected amine are compatible with process-oriented protection/deprotection logic, supporting chemoselective steps that separate amide bond formation from final functional group unveiling. The D-configuration and Ile side-chain sterics help ensure that stereochemical integrity is maintained through intermediate stages that lead to D-amino acid-containing drug-like fragments or peptide-based intermediates. The resulting downstream derivatives can be used as standardized inputs for fine chemical synthesis, peptide fragment assembly, and scalable preparation of protected intermediates for further elaboration.

Size
1 g;5 g;
InChI
1S/C13H19NO2.C7H8O3S/c1-3-10(2)12(14)13(15)16-9-11-7-5-4-6-8-11;1-6-2-4-7(5-3-6)11(8,9)10/h4-8,10,12H,3,9,14H2,1-2H3;2-5H,1H3,(H,8,9,10)/t10-,12-;/m1./s1
InChI Key
XAWVXTVKSVYPNE-MHDYBILJSA-N
Canonical SMILES
CCC(C)C(C(=O)OCC1=CC=CC=C1)N.CC1=CC=C(C=C1)S(=O)(=O)O

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOEpitope Mapping ServicesPeptide Modification ServicesCustom Conjugation ServicePeptide Synthesis ServicesPeptide Nucleic Acids SynthesiscGMP Peptide ServicePeptide Analysis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers